In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
6 weeks 5 days ago
10 weeks 6 days ago
11 weeks 6 days ago
11 weeks 6 days ago
33 weeks 8 hours ago
37 weeks 1 day ago
38 weeks 5 days ago
38 weeks 6 days ago
51 weeks 1 day ago
1 year 4 weeks ago